What sector does Avenue Therapeutics, Inc (ATXI) operate in?
Avenue Therapeutics, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Avenue Therapeutics, Inc (ATXI) current stock price?
As of the latest data, Avenue Therapeutics, Inc stock price is $0.17, with a previous close of $0.22. Avenue Therapeutics, Inc lost -$0.05 in the last trading session, representing a -22.69% loss.
What is Avenue Therapeutics, Inc (ATXI) current market capitalization?
Avenue Therapeutics, Inc market cap is approximately 541.18 thousand.
What is Avenue Therapeutics, Inc (ATXI) Earnings Per Share (EPS)?
The trailing EPS is $0.77.
What is Avenue Therapeutics, Inc (ATXI) Price-to-Earnings (P/E) ratio?
Avenue Therapeutics, Inc current P/E ratio is 0.22.
What is Avenue Therapeutics, Inc (ATXI) EBITDA?
Avenue Therapeutics, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -683.00 thousand.
Does Avenue Therapeutics, Inc (ATXI) pay dividends?
No. Avenue Therapeutics, Inc does not pay a dividend.
What is Avenue Therapeutics, Inc (ATXI) beta (volatility) score?
Avenue Therapeutics, Inc has a beta of -0.513, indicating lower volatility than the overall market.